000 01724nam  2200361zi 4500
0019.872303
003CaOODSP
00520221107163620
006m    go  d f      
007cr |n ||||||||
008190501s2019    onc    #o    f000 0 eng d
040 |aCaOODSP|beng|erda|cCaOODSP
041 |aeng|afre
043 |an-cn---
0861 |aH82-37/2019-PDF
24500|aPressures behind the rising costs in Canadian private drug plans, 2018 = |bPressions à l'origine de la hausse des coûts des régimes privés d'assurance-médicaments au Canada, 2018.
24611|aPressions à l'origine de la hausse des coûts des régimes privés d'assurance-médicaments au Canada, 2018
264 1|a[Ottawa] : |bPatented Medicine Prices Review Board = Conseil d'examen du prix des médicaments brevetés, |c[2019]
300 |a1 online resource (1 page) : |bcoloured graphs
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |a"NPDUIS. National Prescription Drug Utilization Information System. Supporting health care decision making in Canada."
504 |aIncludes bibliographical references.
530 |aIssued also in HTML format.
546 |aText in English and in French.
69207|2gccst|aPrescription drugs
69207|2gccst|aHealth insurance
7101 |aCanada. |bPatented Medicine Prices Review Board.
792 |tPressures behind the rising costs in Canadian private drug plans, 2018 = |w(CaOODSP)9.872309
85640|qPDF|uhttps://publications.gc.ca/collections/collection_2019/cepmb-pmprb/H82-37-2019.pdf|s588 KB
8564 |qHTML|sN/A|uhttp://www.pmprb-cepmb.gc.ca/view.asp?ccid=1448&lang=en